Xenon Pharmaceuticals XENE
NASDAQ XENE
$38.02 -0.91 (-2.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xenon Pharmaceuticals (XENE) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Xenon Pharmaceuticals (XENE) posted Return on Capital Employed [ROCE] of -34.07% for Q2 2026, up 13.01 percentage points from -47.08% a year earlier and up 8.47 percentage points from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Xenon Pharmaceuticals' Return on Capital Employed [ROCE] came in at -55.36%, down 22.34 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for three consecutive years, with a five-year change of -34.99 percentage points (FY2020 to FY2025).
  • In prior years, Xenon Pharmaceuticals' Return on Capital Employed [ROCE] was -33.02% in FY2024 (-7.30 pp), -25.72% in FY2023 (-5.55 pp), -20.17% in FY2022 (+1.40 pp) and -21.57% in FY2021 (-1.20 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in two of the last eight quarters, with an average year-over-year change of -10.96 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2026, with a gain of 13.01 percentage points; the weakest was Q4 2025, with a drop of 28.72 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -42.53% (Q1 2026), -64.47% (Q4 2025) and -56.54% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Xenon Pharmaceuticals 3.68 Bn 3.68 Bn - -34.07%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -34.07%
Mar 31, 2026 -42.53%
Dec 31, 2025 -64.47%
Sep 30, 2025 -56.54%
Jun 30, 2025 -47.08%
Mar 31, 2025 -39.66%
Dec 31, 2024 -35.74%
Sep 30, 2024 -30.78%
Jun 30, 2024 -27.29%
Mar 31, 2024 -24.36%
Dec 31, 2023 -27.07%
Sep 30, 2023 -31.18%
Jun 30, 2023 -27.61%
Mar 31, 2023 -22.51%
Dec 31, 2022 -17.40%
Sep 30, 2022 -14.26%
Jun 30, 2022 -13.17%
Mar 31, 2022 -14.42%
Dec 31, 2021 -19.56%
Sep 30, 2021 -26.13%
API Access

Xenon Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XENE&period=max&api_key=YOUR_API_KEY